Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulf Müller

Showing results (241-250 of 301) with videos related to

Pageof 31
Sort By:
Annals of the Rheumatic Diseases|October 26, 2017
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)Dinesh Khanna, Christopher P Denton, Celia J F Lin, et al.
Swiss Medical Weekly|July 20, 2021
The burden of systemic sclerosis in Switzerland - the Swiss systemic sclerosis EUSTAR cohortJasmin Hernández, Suzana Jordan, Rucsandra Dobrota, et al.
Annals of the Rheumatic Diseases|October 25, 2014
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective studyMuriel Elhai, Jérôme Avouac, Ulrich A Walker, et al.
Annals of the Rheumatic Diseases|June 20, 2025
Influence of canstatin on fibroblast-driven hypervascularisation in rheumatoid arthritisCorinna Heck, Birgit Zimmermann-Geller, Sophie Haun, et al.
RMD Open|October 1, 2019
Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendationsChristien Rondaan, Victoria Furer, Marloes W Heijstek, et al.
Annals of the Rheumatic Diseases|August 16, 2019
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseasesVictoria Furer, Christien Rondaan, Marloes W Heijstek, et al.
The Journal of Rheumatology|April 3, 2019
Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ ComplicationPia Moinzadeh, Kathrin Kuhr, Elise Siegert, et al.
Rheumatology (Oxford, England)|April 8, 2026
Clinical characteristics and risk factors for calcinosis cutis in systemic sclerosis: insights from the EUSTAR databaseAslihan Avanoglu-Guler, Michael Hughes, Giacomo De Luca, et al.
Annals of the Rheumatic Diseases|September 14, 2016
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity indexGabriele Valentini, Michele Iudici, Ulrich A Walker, et al.
Arthritis Research & Therapy|October 25, 2011
Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical featuresRudolf Mierau, Pia Moinzadeh, Gabriela Riemekasten, et al.
Pageof 31

Showing results (241-250 of 301) with videos related to

Sort By:
Pageof 31
Annals of the Rheumatic Diseases|October 26, 2017
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)Dinesh Khanna, Christopher P Denton, Celia J F Lin, et al.
Swiss Medical Weekly|July 20, 2021
The burden of systemic sclerosis in Switzerland - the Swiss systemic sclerosis EUSTAR cohortJasmin Hernández, Suzana Jordan, Rucsandra Dobrota, et al.
Annals of the Rheumatic Diseases|October 25, 2014
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective studyMuriel Elhai, Jérôme Avouac, Ulrich A Walker, et al.
Annals of the Rheumatic Diseases|June 20, 2025
Influence of canstatin on fibroblast-driven hypervascularisation in rheumatoid arthritisCorinna Heck, Birgit Zimmermann-Geller, Sophie Haun, et al.
RMD Open|October 1, 2019
Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendationsChristien Rondaan, Victoria Furer, Marloes W Heijstek, et al.
Annals of the Rheumatic Diseases|August 16, 2019
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseasesVictoria Furer, Christien Rondaan, Marloes W Heijstek, et al.
The Journal of Rheumatology|April 3, 2019
Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ ComplicationPia Moinzadeh, Kathrin Kuhr, Elise Siegert, et al.
Rheumatology (Oxford, England)|April 8, 2026
Clinical characteristics and risk factors for calcinosis cutis in systemic sclerosis: insights from the EUSTAR databaseAslihan Avanoglu-Guler, Michael Hughes, Giacomo De Luca, et al.
Annals of the Rheumatic Diseases|September 14, 2016
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity indexGabriele Valentini, Michele Iudici, Ulrich A Walker, et al.
Arthritis Research & Therapy|October 25, 2011
Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical featuresRudolf Mierau, Pia Moinzadeh, Gabriela Riemekasten, et al.
Pageof 31